Q3 2024 · 13F-HR
CAXTON CORPholdings as filed
Filed 2024-11-14 · accession 0000919574-24-006599
$24.2M
Reported value
12
Positions
2024-09-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 98422E103 | XERS | XERIS BIOPHARMA HOLDINGS INC | $14.6M | 60.3% | 5,113,348 | Common | SOLE |
| 76200L309 | RZLT | REZOLUTE INC | $6.4M | 26.5% | 1,318,967 | Common | SOLE |
| 78462F103 | SPY | SPDR S&P 500 ETF TR | $1.6M | 6.81% | 2,867 | Common | SOLE |
| 084670702 | BRK/B | BERKSHIRE HATHAWAY INC DEL | $529,573 | 2.19% | 1,151 | Common | SOLE |
| 055477103 | BCAX | BICARA THERAPEUTICS INC | $278,669 | 1.15% | 10,941 | Common | SOLE |
| 60255C885 | BRD1EUR | MIND MEDICINE MINDMED INC | $193,876 | 0.80% | 34,073 | Common | SOLE |
| 52886X107 | LXEO | LEXEO THERAPEUTICS INC | $161,374 | 0.67% | 17,851 | Common | SOLE |
| 00370M103 | ABVX | ABIVAX SA | $130,925 | 0.54% | 11,365 | Common | SOLE |
| 501976104 | KYTX | KYVERNA THERAPEUTICS INC | $112,378 | 0.47% | 22,981 | Common | SOLE |
| 20454B104 | CMPX | COMPASS THERAPEUTICS INC | $79,976 | 0.33% | 43,465 | Common | SOLE |
| 21077P108 | CNTX | CONTEXT THERAPEUTICS INC | $36,071 | 0.15% | 18,403 | Common | SOLE |
| 007002108 | TORCEUR | ADICET BIO INC | $25,182 | 0.10% | 17,488 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.